Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $43,947 - $51,388
-444 Reduced 3.96%
10,758 $1.24 Million
Q2 2023

Aug 04, 2023

SELL
$96.34 - $112.38 $5.39 Million - $6.29 Million
-55,971 Reduced 83.32%
11,202 $1.15 Million
Q1 2023

May 11, 2023

SELL
$107.32 - $113.5 $19.8 Million - $20.9 Million
-184,192 Reduced 73.28%
67,173 $7.33 Million
Q4 2022

Feb 07, 2023

BUY
$62.39 - $113.8 $622,964 - $1.14 Million
9,985 Added 4.14%
251,365 $28.6 Million
Q3 2022

Nov 10, 2022

SELL
$58.92 - $84.67 $2.83 Million - $4.07 Million
-48,097 Reduced 16.62%
241,380 $14.9 Million
Q2 2022

Aug 03, 2022

BUY
$79.4 - $116.36 $1.4 Million - $2.05 Million
17,612 Added 6.48%
289,477 $23.1 Million
Q1 2022

May 04, 2022

BUY
$86.42 - $109.81 $106,210 - $134,956
1,229 Added 0.45%
271,865 $28.6 Million
Q4 2021

Feb 04, 2022

BUY
$98.56 - $119.91 $2.41 Million - $2.93 Million
24,472 Added 9.94%
270,636 $29.2 Million
Q3 2021

Oct 07, 2021

BUY
$91.91 - $110.37 $1.4 Million - $1.69 Million
15,269 Added 6.61%
246,164 $27 Million
Q2 2021

Aug 04, 2021

BUY
$86.24 - $95.92 $246,215 - $273,851
2,855 Added 1.25%
230,895 $21.6 Million
Q1 2021

May 04, 2021

BUY
$71.83 - $95.48 $5.38 Million - $7.16 Million
74,941 Added 48.95%
228,040 $21 Million
Q4 2020

Feb 02, 2021

BUY
$67.0 - $84.39 $2.11 Million - $2.65 Million
31,445 Added 25.85%
153,099 $11.2 Million
Q3 2020

Oct 09, 2020

SELL
$55.23 - $79.93 $839,109 - $1.21 Million
-15,193 Reduced 11.1%
121,654 $9.45 Million
Q2 2020

Jul 08, 2020

BUY
$30.2 - $56.98 $1.18 Million - $2.24 Million
39,225 Added 40.18%
136,847 $7.61 Million
Q1 2020

Apr 23, 2020

SELL
$24.87 - $38.56 $177,571 - $275,318
-7,140 Reduced 6.82%
97,622 $2.89 Million
Q4 2019

Feb 11, 2020

BUY
$25.43 - $36.67 $588,755 - $848,983
23,152 Added 28.37%
104,762 $3.79 Million
Q3 2019

Oct 17, 2019

SELL
$23.0 - $27.97 $46,989 - $57,142
-2,043 Reduced 2.44%
81,610 $2.22 Million
Q2 2019

Aug 02, 2019

BUY
$22.81 - $28.48 $1.91 Million - $2.38 Million
83,653 New
83,653 $2.01 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.